Telomere Elongation and Naive Pluripotent Stem Cells Achieved from Telomerase Haplo-Insufficient Cells by Somatic Cell Nuclear Transfer  by Sung, Li-Ying et al.
ReportTelomere Elongation and Naive Pluripotent Stem
Cells Achieved from Telomerase Haplo-Insufficient
Cells by Somatic Cell Nuclear TransferGraphical AbstractHighlightsMouse ntESCs can be efficiently derived from telomerase-
defective cells by SCNT
Terc+/ ntESCs support full-term development by tetraploid
complementation assay
Telomeres of Terc+/mouse cells are effectively elongated in the
derived ntESCs
Telomere lengths are important for naive pluripotency of mouse
ntESCsSung et al., 2014, Cell Reports 9, 1603–1609
December 11, 2014 ª2014 The Authors
http://dx.doi.org/10.1016/j.celrep.2014.10.052Authors






Sung et al. demonstrate in amousemodel
that telomeres of telomerase haplo-insuf-
ficient cells can be elongated by somatic
cell nuclear transfer. Moreover, ntESCs
derived from Terc+/ cells exhibit pluripo-
tency evidenced by generation of
Terc+/ntESC clone pups by tetraploid
embryo complementation, the most strin-
gent test of naive pluripotency.Accession NumbersGSE62692
Cell Reports
ReportTelomere Elongation and Naive Pluripotent Stem
Cells Achieved from Telomerase Haplo-Insufficient
Cells by Somatic Cell Nuclear Transfer
Li-Ying Sung,1,2,3 Wei-Fang Chang,1 Qian Zhang,4 Chia-Chia Liu,1,5 Jun-Yang Liou,5 Chia-Chun Chang,1 Huan Ou-Yang,1
RenpengGuo,4 Haifeng Fu,4Winston T.K. Cheng,1,6 Shih-Torng Ding,1 Chuan-MuChen,7,8Maja Okuka,9 David L. Keefe,10
Y. Eugene Chen,11 Lin Liu,4,* and Jie Xu11,*
1Institute of Biotechnology, National Taiwan University, Taipei, 106 Taiwan, ROC
2Agricultural Biotechnology Research Center, Academia Sinica, Taipei, 115 Taiwan, ROC
3Research Center for Developmental Biology and Regenerative Medicine, National Taiwan University, Taipei, 100 Taiwan, ROC
4State Key Laboratory of Medicinal Chemical Biology and Collaborative Innovation Center for Biotherapy, Department of Cell Biology and
Genetics, College of Life Sciences, Nankai University, Tianjin 300071, China
5Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, 350 Taiwan, ROC
6Department of Animal Science and Biotechnology, Tunghai University, Taichung, 407 Taiwan, ROC
7Department of Life Sciences, and Agricultural Biotechnology Center, National Chung Hsing University, Taichung, 402 Taiwan, ROC
8Rong-Hsing Translational Medicine Center and iEGG Center, National Chung Hsing University, Taichung, 402 Taiwan, ROC
9Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa, FL 33612, USA
10Department of Obstetrics and Gynecology, New York University Langone Medical Center, New York, NY 10016, USA
11Center for AdvancedModels for Translational Sciences and Therapeutics, University ofMichiganMedical Center, Ann Arbor,MI 48109, USA
*Correspondence: liulin@nankai.edu.cn (L.L.), jiex@umich.edu (J.X.)
http://dx.doi.org/10.1016/j.celrep.2014.10.052
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).SUMMARY
Haplo-insufficiency of telomerase genes in humans
leads to telomere syndromes such as dyskeratosis
congenital and idiopathic pulmonary fibrosis. Gener-
ation of pluripotent stem cells from telomerase
haplo-insufficient donor cells would provide unique
opportunities toward the realization of patient-spe-
cific stem cell therapies. Recently, pluripotent human
embryonic stem cells (ntESCs) have been efficiently
achieved by somatic cell nuclear transfer (SCNT).
We tested the hypothesis that SCNT could effectively
elongate shortening telomeres of telomerase haplo-
insufficient cells in the ntESCs with relevant mouse
models. Indeed, telomeres of telomerase haplo-
insufficient (Terc+/) mouse cells are elongated in
ntESCs.Moreover, ntESCs derived from Terc+/ cells
exhibit naive pluripotency as evidenced by gene-
ration of Terc+/ ntESC clone pups by tetraploid
embryo complementation, the most stringent test
of naive pluripotency. These data suggest that
SCNT could offer a powerful tool to reprogram telo-
meres and to discover the factors for robust restora-
tion of telomeres and pluripotency of telomerase
haplo-insufficient somatic cells.INTRODUCTION
Mammalian telomere lengths are primarily regulated by telome-
rase, consisting of a reverse transcriptase protein (TERT), aCell ReRNA subunit (TERC), and stabilizing proteins including dyskerin,
in a temporally and spatially dependent manner (Gu¨nes and Ru-
dolph, 2013). Telomerase activity is high during early embryo
development, but becomes undetectable in most adult cells in
humans. Mutations of genes that encode telomerase compo-
nents, TERT, TERC, or DKC1, cause premature aging and age-
related diseases, including aplastic anemia, dyskeratosis
congenital, and idiopathic pulmonary fibrosis, collectively referred
to as ‘‘telomere syndromes’’ to reflect the short and dysfunctional
telomeres commonly found in these patients’ cells (Armanios and
Blackburn, 2012). Heterozygous mutations of TERT and TERC
represent major mutations in genetically defined telomere syn-
dromes. Mutations of telomerase components are also associ-
ated with decreased fertility in both animals and humans (Herrera
et al., 1999; Yan et al., 2014).
Stem cell failure in highly proliferative tissues, such as hemato-
poietic stem cells, due to progressive telomere loss caused by
insufficient telomerase activity is considered as an important
therapeutic target for telomere syndromes (Armanios and Black-
burn, 2012). Indeed, allogeneic stem cell transplantation can
reverse the aplastic anemia phenotype (Armanios and Black-
burn, 2012; Young et al., 2006). However, it has been a challenge
to establish patient-specific induced pluripotent stem (iPS) cells
with proper restoration of telomere defects using donor cells
from patients with telomere syndrome (Batista et al., 2011; Win-
kler et al., 2013).
Efficient generation of human pluripotent embryonic stem
cells (ntESCs) with somatic cell nuclear transfer (SCNT) using
oocyte factors represents a major advancement toward the real-
ization of patient-specific cell therapies (Chung et al., 2014; Ta-
chibana et al., 2013; Yamada et al., 2014). Mouse ntESCs are
transcriptionally and functionally indistinguishable from ESCs
generated from fertilized embryos (Brambrink et al., 2006;ports 9, 1603–1609, December 11, 2014 ª2014 The Authors 1603
Wakayama et al., 2001). Human ntESCs also closely resemble
ESCs (Chung et al., 2014; Tachibana et al., 2013). Moreover,
mice can be recloned by SCNT for more than 25 generations,
without accumulation of errors, and show proper telomere main-
tenance (Wakayama et al., 2013). Earlier this year, Le et al. (2014)
reported that telomeres in Terc null mouse cells were reprog-
rammed after SCNT; however, they did not investigate whether,
and to what extent, the telomeres of telomerase haplo-insuffi-
cient cells, which represents the majority of genotype-defined
telomere syndrome patients, can be regenerated in ntESCs.
The developmental pluripotency of telomerase insufficient
ntESCs also remains to be determined. We performed experi-
ments in order to test whether naive pluripotent stem cells with
robust telomere elongation can be derived via SCNT from telo-
merase defective donor cells, using donor cells from Terc+/
mice in comparison with G2 Terc/ mice.
RESULTS
Development of Cloned Embryos and Derivation
of ntESCs from Telomerase-Deficient Cells
We performed SCNT using tail tip fibroblast (TTF) cells as donor
cells isolated from heterozygous Terc (Terc+/) C57BL/6 mice, in
comparison with wild-type (WT) and G2 homozygous Terc KO
(Terc/) mice. High rates of blastocyst (BL) development
(Terc+/: 43.7%; Terc/: 64.9% versus WT: 73.7%) were
achieved, despite telomerase deficiency (Figure S1A). BLs of
different Terc genotypes are morphologically indistinguishable
(Figure 1A).
We next mechanically dissected the inner cell mass from
these cloned embryos and plated them on feeder cells to derive
ntESCs. The efficiencies of ntESC derivation were similar
among three groups (WT: 17.4%; Terc+/: 19.1%; Terc/:
19.5%, Figure S1B). These ntESC lines (Figure 1B) showed
characteristics typical of mouse ESC markers (Oct4, Nanog,
Sox2, and SSEA1) by immunofluorescence microscopy (Fig-
ure S1D), expressed pluripotent genes as measured by
RT-PCR (Oct4, Sox2, Nanog, and Rex1; Figure S1E), and main-
tained normal karyotypes (66.6%–86.7%), regardless of their
genotypes (Figure S1C). These results demonstrate that telo-
merase deficiency does not significantly compromise the
in vitro development of cloned embryos and the derivation of
ntESC lines.
Telomerase Haplo-Insufficient ntESCs Show
Naive Pluripotency
Previously, we established WT mouse ntESCs and demon-
strated that they support full-term development by tetraploid
embryo complementation (TEC) (Sung et al., 2010), the most
stringent test of naive pluripotency (Jaenisch and Young,
2008). Here we tested naive pluripotency of Terc+/ and Terc/
ntESC lines with TEC (Figures 1C and D) to determine whether
these cells are capable of supporting full-term development.
We injected Terc+/ ntESCs with C57BL/6 genetic background
to tetraploid embryos (n = 368, ICR background) bymicromanip-
ulation and transferred the embryos to ten recipients (ICR back-
ground, Figure 1G). Twenty-eight cloned Terc+/ntESC pups
were born, with a term-development rate of 7.6% (Figures 1E1604 Cell Reports 9, 1603–1609, December 11, 2014 ª2014 The Autand H), comparable to that of WT ntESCs (2%) (Sung et al.,
2010), and that of Terc+/ ESCs derived from normally fertilized
embryos (9%) (Huang et al., 2011). All Terc+/ pups showed
C57BL/6 genetic background by microsatellite analysis, in
contrast to the corresponding placentas with ICR background,
confirming the clonal origin of the pups from the Terc+/ ntESCs
(Figure 1F). However, 350 tetraploid embryos injected with
Terc/ ntESCs failed to produce any pups (Figure 1E), indi-
cating significantly compromised in vivo pluripotency of Terc/
ntESCs, resembling Terc/ ESCs (Huang et al., 2011). These
data show that telomerase haplo-insufficient ntESCs are ca-
pable of supporting full-term development, functionally vali-
dating their naive pluripotent state.
Robust Telomere Elongation in Telomerase
Haplo-Insufficient ntESCs
Telomere lengths highly correlate with the developmental plurip-
otency of ESCs/iPSCs (Huang et al., 2011). To determine
whether telomere lengths are elongated in ntESCs with high
developmental pluripotency, we measured relative telomere
content/length (RTL) with qPCR, shown as relative telomere to
single copy gene (T/S) ratio (Callicott and Womack, 2006), of
donor fibroblast cells and ntESC lines.
SCNT effectively restored telomeres in all WT ntESCs (RTL
1.11–1.14), compared to those of donor TTFs (RTL 0.95, Fig-
ure 2A). In contrast, Terc/ ntESCs had shorter RTLs in all lines
examined (0.82–0.87), similar to those of donor TTFs (0.86) (Fig-
ure 2A), suggesting failure of telomere elongation due to lack of
telomerase. Interestingly, RTLs of Terc/ ntESCs were main-
tainedat similar level to thoseof donor cells, rather thanshortening
without telomerase, after ntESC derivation and in vitro culture,
suggesting that telomerase-independent mechanisms may be
activated to slow down telomere attrition in these cells.
Notably, telomere lengths of all Terc+/ ntESCs (1.00–1.04)
were robustly elongated to reach levels significantly longer
than those of donor TTFs (RTL 0.91) and Terc/ ntESCs (RTL
0.82–0.87) (Figure 2A). Differences in telomere lengths between
Terc+/ and Terc/ ntESCs coincided with the outcomes of
TEC experiments.
To validate the findings obtained by qPCR, we measured telo-
mere lengths using Southern blot-based telomere restriction
fragment (TRF) analysis (Figure 2B) (Blasco et al., 1997). Consis-
tent with the qPCR findings, telomeres were elongated robustly
in WT, and also in Terc+/, but not in Terc/ ntESCs, compared
with their donor cells. We also measured telomere length and
function (telomere integrity and chromosome stability) of ntESCs
by telomere quantitative fluorescent in situ hybridization (Q-
FISH) (Figure 2C). Relative telomere lengths shown as telomere
fluorescence intensities (telomere fluorescence unit, TFU) were
shorter in TTFs of all three genotypes, but a correlation of the
TFU with telomerase sufficiency was found with the TFU highest
in WT (36.37 ± 13.75), followed by Terc+/ (29.02 ± 13.85), and
lowest in Terc/ TTF cells (23.44 ± 12.82). Consistent with
qPCR data, telomeres shown as TFUs were significantly elon-
gated in both WT (57.69–61.65) and Terc+/ (42.65–46.94), and
only slightly elongated in Terc/ (25.64–27.05) ntESCs,
compared with those of their donor TTF cells. Consistently, telo-
mere signal-free ends, indicative of telomere loss, were onlyhors
Figure 1. Production of All Terc+/ ntESC Pups by Tetraploid Embryo Complementation Assay
(A) Morphology of cloned embryos at blastocyst stage. Scale bar represents 100 mm.
(B) Morphology of ntESCs at Passage 5 under transmitted microscopy. Scale bar represents 100 mm.
(C) Illustration of the tetraploid embryo complementation assay. A tetraploid embryo at blastocyst stage (shown in orange) is used as the host embryo. The
ntESCs (shown in blue) are injected into host embryos followed by embryo transfer. The tetraploid host embryo will only contribute to the placenta (orange),
whereas all embryonic tissues are originated from ntESC (blue).
(D) Microscopic images of ntESC injection in the TEC assay. Scale bar represents 25 mm.
(E) Success rates of ntESC pups by TEC assays. 4N-BL, tetraploid blastocyst.
(F) Confirmation of specific origin of Terc+/ntESC clones by microsatellite genotyping using D18Mit17 primers (top gel) and D12Mit136 primers (bottom gel). M,
molecular marker. 1: Terc+/ donor fibroblast cells. 2: Terc+/ntESC line 7. 3–5: pups derived from Terc+/ ntESC line 7. 6–8: placenta from Terc+/ntESC clones.
9:WTB6mouse. 10: ICRmouse. 11: BDF1mouse. N, blank. Samples from Terc+/ fibroblast donor cells, Terc+/ntESC line 7, and ntESC pups (lanes 1–5) show a
single band (top arrow, 213 bp) for D18Mit17, and a single band (bottom arrow, 147 bp) for D12Mit136, the same pattern as WT C57BL/6 mouse (lane 9);
whereas samples from placenta (lanes 6–8, ICR origin), surrogate mouse (lane 10, ICR), and oocyte donor (lane 11, BDF1) show different patterns with two bands
for D18Mit17 (188 and 213 bp) and a band at 191 bp for D12Mit136.
(G) Surrogate mouse (ICR origin, albino coat, and red eyes).
(H) Newborn pups derived entirely from Terc+/ ntESCs (black eyes).
(I) Adult Terc+/ ntESC Clone 3 (black coat and black eyes from C57BL/6 origin).
(J) Three adult Terc+/ntESC clones.
(K) Pups fathered by Clone 3 after breeding with a WT C57BL/6 female.
See also Figure S1.observed in Terc/ (red arrows, Figure 2D) donor and ntES
cells, but not in WT and Terc+/ ntESCs.
Telomere Lengths in Cloned Pups Derived from
Telomerase Haplo-Insufficient ntESCs
We measured telomeres as RTLs of TTFs in cloned pups as well
as their corresponding placentas (Figure 3A). The clones were
entirely derived from Terc+/ ntESCs of C57BL6 background
with black coat color and confirmed by microsatellite genotyp-
ing, while the placentas were derived from WT tetraploid host
embryo origin of ICR background.Cell ReRTLs of all clones measured (1.03–1.23) were similar to those
of donor ntESCs (1.07 ± 0.07). RTLs of all placentas fell in a com-
parable range (1.07–1.19, Figure 3A). These data show that full-
term clone pups from Terc+/ ntESC had telomere lengths like
those of donor ntESCs.
Terc+/ Clones Are Fertile and Do Not Show Signs of
Premature Aging
Three clones produced from Terc+/ ntESCs have reached adult-
hood when we prepare this manuscript (Figure 1I and J). They all
appear normal and healthy and show no signs of prematureports 9, 1603–1609, December 11, 2014 ª2014 The Authors 1605
Figure 2. Telomere Lengths in ntESCs
(A) Relative T/S ratio (mean ± SEM) in ntESCs of different genotypes. TTF, tail-tip fibroblast. Comparisons within the same genotype were made with TTF.
(B) TRF analysis of ntESCs.
(C) Histogram shows distribution of relative telomere length expressed as fluorescence intensity (TFU). Heavy black bars on the y axis indicated by arrows show
number of telomere signal-free ends. Average telomere length is shown as mean TFU ± SD. TTF, tail-tip fibroblast donor cells. Numbers following genotype
indicate ntESC line number.
(D) Representative telomere Q-FISH images of ntESCs at P6. Telomeres are labeled with telomere PNA probes (green), and chromosomes labeled with DAPI
(blue). Red arrows: telomere free ends, indicative of telomere loss. *p < 0.05; **p < 0.01; ***p < 0.001.
See also Figures S2 and S3.aging. We compared RTLs of Terc+/ ntESCs, TTFs of Clone 3
(the oldest of all) at newborn and at 4 months old and found no
differences in telomere lengths among them, indicating that telo-
mere lengths are properly maintained after birth and at least until
4 months of age (Figure 3B). Moreover, Clones 3 and 5 (male)
were recently proven fertile. After breeding with WT females,
they have fathered eight and six apparently normal pups, respec-
tively (pups fathered by Clone 3 shown in Figure 1K).1606 Cell Reports 9, 1603–1609, December 11, 2014 ª2014 The AutComplete Telomerase Deficiency Reduces Proliferation
of ntESCs
Considering the fundamental roles of telomeres and telomerase
in proliferation, we assessed proliferation rates of ntESCs with
different levels of telomerase activity (Figure S1F). We seeded
100,000 cells on day 0 (D0) and counted the cell number on
D2, D4, and D6. Number of cells on D6 was used as an indicator
of cell proliferation rate. Terc/ ntESCs, with shortest telomeres,hors
Figure 3. Telomere Lengths in All Terc+/
ntESC Cloned Pups
(A) Relative T/S ratio (mean ± SEM) in Terc+/
ntESCs, in TTFs of clones and their corresponding
placentas. ntESCs: Terc+/ ntESC line 5.
(B) Relative T/S ratio (mean ± SEM) in ntESCs, and
in the TTFs of Clone 3 at different ages.turned out to proliferate at a much slower rate compared to
Terc+/ and WT cells. Interestingly, Terc haplo-insufficient
ntESCs proliferated at rates faster than WT ones. These data
suggest that deficiency in self-renewal capacity may also
contribute to the inability of Terc/ ntESCs to support embryo
generation by TEC assay, in addition to the compromised
pluripotency.
Differential Expression of Genes Involved in
Telomere Regulation
To gain insights into molecular differences in telomere lengths
and pluripotency, we performedmicroarray of ntESCs with three
genotypes using Illumina Mouse Ref-8 chips. One hundred nine-
teen genes of over 25,697 (0.46%) genes were differentially
expressed at 2.0-fold or higher between the WT and Terc/
ntESCs.
Pairwise scatter plots (Figure S3A) suggest that expression of
genes routinely used as markers of pluripotency, including Oct4,
Nanog, Esrrb2, and Klf4, did not differ significantly among WT,
Terc+/, and Terc/ ntESCs, consistent with data by immuno-
staining, RT-PCR (FiguresS1DandS1E), andqPCR (Figure S3B).
Our data support the notion that the conventional ES cell plurip-
otency markers cannot reliably distinguish ntESCs/ESCs with or
without telomerase, nor can they indicate the naive develop-
mental potency (Huang et al., 2011).
We also examined a number of genes related to telomere
length regulation in the array data, followed by validation with
qPCR. Probes for Terc were not in the array, unfortunately, but
qPCR revealed that its expression was high in WT, moderate in
Terc+/, and undetectable in the Terc/ cells, faithfully reflect-
ing their corresponding genotypes (Figure S3C). Both array
and qPCR showed that expressions of Tert, along with several
other genes (i.e., Pot1a, Terf1, Terf2, Rtel1, Tep1, and Pinx1)
did not differ among these ntESCs (Figures S3A and S3C).
Notably, Zscan4, a key gene in telomerase-independent telo-
mere elongation based on recombination (Zalzman et al.,
2010), was found differentially expressed in these ntESCs (Fig-
ure S3A). Quantitative PCR (Figure S3C) and western blot (Fig-
ure S3D) confirmed that Zscan4 expression was upregulated in
the Terc/ ntESCs, compared to WT and Terc+/ ntESCs.
In addition, we analyzed telomere sister chromatid exchange
(T-SCE), indicative of telomere recombination, of WT, Terc+/
and Terc/ TTFs and ntESCs using co-FISH (Wang et al.,
2012). Terc/ ntESCs exhibited increased frequency of T-
SCEs than did WT and Terc+/ cells (Figure S2), a pattern similar
to those of Terc/ iPSCs (Wang et al., 2012), coinciding withCell Reports 9, 1603–1609, DeZscan4 expression levels of ntESCs of
different Terc genotypes (Figures S3C
and S3D). To test whether Zscan4 isinvolved in maintaining telomeres of Terc/ cells, we performed
Zscan4 knockdown experiments in Terc/ ntESCs using two in-
dependent shRNA sequences, based on the methods described
(Dan et al., 2014). Indeed, Zscan4 knockdown resulted in telo-
mere shortening in Terc/ ntESCs (Figures S3E–S3G). These
data suggest that telomerase deficiency and short telomeres
eventually induce telomere recombination events, likely through
activation of Zscan4, and that Zscan4 plays important roles in
maintaining telomeres in telomerase-deficient cells.
DISCUSSION
We suggest that naive pluripotent patient-specific stem cells can
be established with robust telomere regeneration from telome-
rase haplo-insufficient cells via SCNT. This may have implica-
tions for cell-based therapies for patients with telomere syn-
drome. Human iPSCs derived from cells with haplo-insufficient
telomerase genes have so far failed to fully restore telomeres
(Batista et al., 2011; Winkler et al., 2013). Winkler et al. derived
iPSCs from patients with aplastic anemia or hypocellular bone
marrow carrying heterozygous mutations in TERT or TERC
(Winkler et al., 2013). The telomeres in these telomerase haplo-
insufficient iPSCs were elongated but at a lower extent com-
paring to the healthy iPSCs. Furthermore, these iPSCs showed
defective hematopoietic differentiation in vitro (Winkler et al.,
2013). Consistently, we showed that iPSCs generated from telo-
merase haplo-insufficient isogenic mouse TTFs used in the pre-
sent work also exhibit only limited telomere elongation and failure
to produce complete iPSC pups (Wang et al., 2012).
Remarkably, telomeres of Terc+/ ntESCs are effectively elon-
gated compared to the donor cells, and the Terc+/ ntESCs
contribute to full-term development by TEC test, indicating naive
pluripotency. Moreover, Terc+/ ntESC clones are fertile and do
not show signs of premature aging, and their offspring appear
normal. While reactivation of Tercmay allow telomere elongation
in telomerase defective iPSCs following prolonged passages
(Agarwal et al., 2010), SCNT-mediated telomere reprogramming
of Terc haplo-insufficient cells does not appear to engage over-
activation of Terc (Figure S3C). Instead, telomerase-indepen-
dent mechanisms (Liu et al., 2007; Zalzman et al., 2010) may
have contributed to the robust reprogramming of telomeres in
Terc+/ ntESCs, which is supported by a recent report that telo-
meres of Terc/ cloned blastocysts are longer than those of
donor cells used for SCNT (Le et al., 2014), as well as the present
study. Previously we and others have shown that Zscan4 plays
important roles in telomerase-independent mechanisms forcember 11, 2014 ª2014 The Authors 1607
iPSC reprogramming (Amano et al., 2013; Falco et al., 2007; Hir-
ata et al., 2012; Jiang et al., 2013; Zalzman et al., 2010). In the
present work, we show that elevated Zscan4 levels are corre-
lated with increased telomere recombination events in the
Terc/ ntESCs and that Zscan4 knockdown in these cells led
to shortened telomeres, implicating the potential roles of Zscan4
in telomere maintenance of ntESCs.
It is intriguing that the second generation or even third gener-
ation Terc/ mice in our breeding colony, similar to those re-
ported by others previously (Herrera et al., 1999), are viable,
whereas no viable pups generated from G2 Terc/ ntESCs in
the present work by TEC, and from conventional (i.e., derived
from fertilized embryos) G1/3/4 Terc/ ESCs in our earlier
work (Huang et al., 2011). We speculate that at least two factors
might have contributed to the failure of the development of
Terc/ ntESCs by TEC assays. First, telomere defects shown
by loss of telomeres, rather than telomerase deficiency or abso-
lute telomere length, could be the major factor for the failed
development. Terc or telomerase deficiency itself unlikely imme-
diately affects telomere function, since mouse telomeres are
long, but the processes of ESC derivation and high proliferation
of ESCs can rapidly shorten telomeres with passages, resulting
in telomere loss and dysfunction. Although increased expression
of Zscan4 can partly compensate for telomere shortening,
thus maintains telomeres at relatively stable lengths without
net shortening of average telomere lengths, telomere free-
signals indicative of telomere loss and chromosome fusion
were found in Terc/ ntESCs, but not WT and Terc+/ ntESCs
(Figure 2D), like those of Terc/ ESCs (Huang et al., 2011).
These defects of telomeres likely contribute to failure in embry-
onic development of G2 Terc/ ntESCs in the present study,
and of G1 and G3/4 Terc/ ESCs in an earlier study (Huang
et al., 2011). Second, reduced cell proliferation of Terc/
ntESCs is a factor. We show that complete telomerase defi-
ciency reduces proliferation of ntESCs (Figure S1F), suggesting
that deficiency in self-renewal capacity may also have contrib-
uted to the inability of Terc/ ntESCs to support full-term devel-
opment by TEC assay.
Our work in chorus with several recent publications (Le et al.,
2014; Li et al., 2014) arguably suggest that ntESCs appear to
have certain advantages over their iPSC counterparts, and that
at its minimum, researchers should aim to improve the iPSCs’
quality to the level of ntESCs. In particular, SCNT may provide
a strategy for correcting telomere deficiencies in patients with
telomere syndrome. An early animal cloning study showed that
telomere lengths of senescent somatic cells can be elongated
by SCNT, even beyond those of newborns (Lanza et al., 2000).
Understanding SCNT-mediated telomere reprogramming would
likely provide insights to improve iPSCs by identifying factors in
oocytes to optimally reset telomeres. These ntESC lines are also
valuable in vitro models to study telomere biology, especially
considering the fact that stem cell failure is a common pathophys-
iological mechanism underling many of the telomere syndromes.EXPERIMENTAL PROCEDURES
Full experimental procedures are available in the Supplemental Experimental
Procedures.1608 Cell Reports 9, 1603–1609, December 11, 2014 ª2014 The AutAnimals
Animal maintenance, care, and use procedures were reviewed and approved
by the Institutional Animal Care and Use Committee (IACUC) of National
Taiwan University. Heterozygous telomerase-deficient (Terc+/) mice
C57B6.Cg-Terctm1Rdp/J were purchased from the Jackson Laboratory, and
housed and bred for generation of Terc/mice. The Terc-deficient mice (Her-
rera et al., 1999; Huang et al., 2011) used in this work were at Generation 2 (G2).
SCNT, ntESC Derivation, and Tetraploid Embryo
Complementation Assay
SCNTwas carried out using a previously described fusion method (Sung et al.,
2010). The spindle chromosome complex was removed using a pipette with an
inner diameter of 8–10 mm assisted by piezo-drill pulses. Nuclei from donor
cells were transferred by electrofusion to produce cloned embryos. When em-
bryos reached the blastocyst stage after 4 days in culture, they were used to
establish ES cell lines as we described previously (Sung et al., 2010). In TEC
assay, ICR strain mice were used to generate tetraploid blastocysts. For
ESC injections, 10–15 ES cells were injected into one blastocyst using a flat
tip pipette with an inner diameter of 14–16 mm assisted by piezo-drill pulses.
Tetraploid blastocysts containing injected ESCs were transferred to pseudo-
pregnant recipient ICR females. The full-term pups were obtained from recip-
ient mothers at day 18.5 by Caesarean section.
Telomere Measurements
Telomere lengths/contents were measured by qPCR (Callicott and Womack,
2006), TRF analysis, and/or telomere Q-FISH. In qPCR, the telomere signal
was normalized to the signal from the single-copy gene (36B4) to generate a
T/S ratio indicative of relative telomere length of the given sample. The TRF
analysis was performed using a commercial kit (TeloTAGGG Telomere Length
Assay, catalog no. 12209136001, Roche Diagnostics). Telomere Q-FISH was
used to estimate telomere length and function (telomere integrity and chromo-
some stability) as described previously (Huang et al., 2011; Wang et al., 2012).
Statistical Analysis
Percentages were transformed with arcsin transformation. Percentage trans-
formed data and other numbers were analyzed by ANOVA and means
compared by Fisher’s LSD usingGraphpad Prism (v6.02, Graphpad Software).
Significant differences were defined as p < 0.05 (*), 0.01 (**), and 0.001 (***).
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The NCBI Gene Expression Omnibus accession number for the gene expres-
sion array data sets reported in this paper is GSE62692.
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